CREDIT AGREEMENT by and among ANGIOTECH PHARMACEUTICALS, INC. as Parent, THE SUBSIDIARIES OF PARENT LISTED AS BORROWERS ON THE SIGNATURE PAGES HERETO as Borrowers, THE LENDERS THAT ARE SIGNATORIES HERETO as Lenders, and WELLS FARGO CAPITAL FINANCE,...Credit Agreement • May 16th, 2011 • Angiotech Pharmaceuticals Inc • Surgical & medical instruments & apparatus • New York
THIS CREDIT AGREEMENT (this “Agreement”), is entered into as of May 12, 2011, by and among the lenders identified on the signature pages hereof (such lenders, together with their respective successors and permitted assigns, are referred to hereinafter each individually as a “Lender” and collectively as the “Lenders”), WELLS FARGO CAPITAL FINANCE, LLC, a Delaware limited liability company, as the arranger and administrative agent for the Lenders (in such capacity, together with its successors and assigns in such capacity, “Agent”), ANGIOTECH PHARMACEUTICALS, INC., a corporation organized under the laws of the Province of British Columbia, Canada (“Parent”), and each of Parent’s Subsidiaries listed as a “Borrower” on the signature pages hereto (each a “Borrower” and collectively, jointly and severally, “Borrowers”).
ANGIOTECH PHARMACEUTICALS, INC. AND EACH OF THE GUARANTORS PARTY HERETO SENIOR SECURED FLOATING RATE NOTES DUE 2013 INDENTURE Dated as of May 12, 2011 Deutsche Bank National Trust Company TrusteeIntercreditor Agreement • May 16th, 2011 • Angiotech Pharmaceuticals Inc • Surgical & medical instruments & apparatus • New York
INDENTURE dated as of May 12, 2011 among Angiotech Pharmaceuticals, Inc., a corporation organized under the Business Corporations Act of the Province of British Columbia, the Guarantors (as defined) and Deutsche Bank National Trust Company, as trustee.
ANGIOTECH PHARMACEUTICALS, INC. RESTRICTED SHARE UNIT AWARD AGREEMENT (for Canadian Participants)Restricted Share Unit Award Agreement • May 16th, 2011 • Angiotech Pharmaceuticals Inc • Surgical & medical instruments & apparatus • British Columbia
Angiotech Pharmaceuticals, Inc. (the “Company”) hereby grants the following award to the Participant named below in accordance with and subject to the terms, conditions and restrictions of this Award Agreement, together with the provisions of the 2011 Stock Incentive Plan of the Company (the “Plan”) dated May 12, 2011:
ANGIOTECH PHARMACEUTICALS, INC. STOCK OPTION/SAR AWARD AGREEMENT (for Canadian Participants)Sar Award Agreement • May 16th, 2011 • Angiotech Pharmaceuticals Inc • Surgical & medical instruments & apparatus
Angiotech Pharmaceuticals, Inc. (the “Company”) hereby grants the following Award to the Participant named below (the “Participant”), in accordance with and subject to the terms, conditions and restrictions of this Award Agreement, together with the provisions of the 2011 Stock Incentive Plan (the “Plan”) of the Company dated May 12, 2011:
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • May 16th, 2011 • Angiotech Pharmaceuticals Inc • Surgical & medical instruments & apparatus • New York
This Registration Rights Agreement (this “Agreement”) is made as of May 12, 2011, by and among Angiotech Pharmaceuticals, Inc., a corporation organized under the Business Corporations Act of the Province of British Columbia (the “Company”) and each of the parties listed on the signature pages hereto (the “Consenting Noteholders”)
ANGIOTECH PHARMACEUTICALS, INC., THE GUARANTORS named herein and DEUTSCHE BANK NATIONAL TRUST COMPANY, as Trustee SUPPLEMENTAL INDENTURE Dated as of May 12, 2011 TO INDENTURE Dated as of December 11, 2006 Senior Floating Rate Notes due 2013Supplemental Indenture • May 16th, 2011 • Angiotech Pharmaceuticals Inc • Surgical & medical instruments & apparatus • New York
SUPPLEMENTAL INDENTURE dated as of May 12, 2011 (this “Supplemental Indenture”), to the Indenture dated as of December 11, 2006 (as amended, supplemented or otherwise modified from time to time, the “Indenture”) among Angiotech Pharmaceuticals, Inc., a corporation organized under the Business Corporation Act of the Province of British Columbia (the “Company”), the Guarantors (as defined in the Indenture) and Deutsche Bank National Trust Company, as successor to Wells Fargo Bank, N.A., as trustee (the “Trustee”) under the Indenture. All capitalized terms used but not otherwise defined herein shall have the meaning assigned thereto in the Indenture.
ANGIOTECH PHARMACEUTICALS, INC. STOCK OPTION/SAR AWARD AGREEMENT (for U.S. Participants)Angiotech Pharmaceuticals Inc • May 16th, 2011 • Surgical & medical instruments & apparatus
Angiotech Pharmaceuticals, Inc. (the “Company”) hereby grants the following Award to the Participant named below (the “Participant”), in accordance with and subject to the terms, conditions and restrictions of this Award Agreement, together with the provisions of the 2011 Stock Incentive Plan (the “Plan”) of the Company dated May 12, 2011:
ANGIOTECH PHARMACEUTICALS, INC. RETRICTED STOCK AWARD AGREEMENT (for U.S. Participants)Retricted Stock Award Agreement • May 16th, 2011 • Angiotech Pharmaceuticals Inc • Surgical & medical instruments & apparatus • British Columbia
Angiotech Pharmaceuticals, Inc. (the “Company”) hereby grants the following Award to the Participant named below (the “Participant”), in accordance with and subject to the terms, conditions and restrictions of this Award Agreement, together with the provisions of the 2011 Stock Incentive Plan (the “Plan”) of the Company dated May 12, 2011:
